Hassan Al-Ali

Research Assistant Professor of Neurological Surgery and Medicine
UNIVERSITY OF MIAMI

Brian Axe

Principal
NOVAQUEST CAPITAL MANAGEMENT

Michael Batten, M.D., MBA

Director, T1D Fund
JDRF

Marco Biamonte

President
DRUGS & DIAGNOSTICS FOR TROPICAL DISEASES

John Billington, J.D., MPH

Director U.S. Public Policy Vaccines
GSK

Bruce Bloom

CEO
CURES WITHIN REACH

Richard Colvin, M.D., Ph.D.

Executive Director, Senior Translational Medicine Expert
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH (NIBR)

Jennifer R. Cook

Manager — Valuation and Business Analytics
BDO

Leslie Cousens

Director, Translational Medicine Emerging Innovations
ASTRAZENECA

Forrest Cox

Co-Founder and SVP, Corporate and Business Development
AFFIGEN

Neal M. Farber

CEO
NEUROHEALING PHARMACEUTICALS, INC.

Rebecca Fish

Vice President, Marketing and Product Strategy, Biodefense Division
EMERGENT BIOSOLUTIONS

Ted FitzGerald, M.S.

Director, Global Research Services
FHI 360

Phillip L. Gomez, Ph.D.

CEO
SIGA TECHNOLOGIES, INC.

Mark Hasleton

Senior Director, Global NTE Pipeline Manager
TEVA PHARMACEUTICALS

Adam Kaplin

Assistant Professor of Psychiatry and Behavioral Sciences
JOHNS HOPKINS HOSPITAL

Curt H. LaBelle, M.D., MBA

President
GLOBAL HEALTH INVESTMENT FUND

Kenneth LaMontagne, Ph.D., MBA

Vice President, Research, Therapy Acceleration Program
THE LEUKEMIA and LYMPHOMA SOCIETY

Bill Lin, Ph.D.

Global Program Leader, Neglected Tropical Diseases (retired)
JOHNSON & JOHNSON

Zhichao Liu

Principal Investigator
FDA

Patrick Lucy

Chief Business Officer
PFENEX

Bobbie Mount

Program Officer, Drug Development Partnership Programs
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES, NIH

Charbel Moussa

Director, Laboratory for Dementia and Parkinsonism
GEORGETOWN UNIVERSITY MEDICAL CENTER

William D. Paiva, Ph.D.

Executive Director, Center for Health Systems Innovation (CHSI)
OKLAHOMA STATE UNIVERSITY

Aris Persidis

President and Co- Founder
BIOVISTA

Prashant Raykar

Senior Manager, Corporate Development
EMERGENT BIOSOLUTIONS

Scott Requadt, J.D., MBA

Managing Director
CLARUS

David Ridley, Ph.D.

Faculty Director, Health Sector Management, Fuqua School of Business
DUKE UNIVERSITY

Leonard Sacks, M.D.

Associate Director for Clinical Methodology, Office of Medical Policy
CDER, FDA

Serge Sagodira, Ph.D.

Director of Business Development and Legal
DRUGS FOR NEGLECTED DISEASES INITIATIVE (DNDI)

Philip E. Sanderson, Ph.D.

Project Leader and Manager, Therapeutics for Rare and Neglected Diseases
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES, NCATS

Amrit Shahzad, MBBS, MBA

Industry Alliance Officer
UC SAN DIEGO

Anita Staud

Senior Manager Business Development
DRUGS FOR NEGLECTED DISEASES INITIATIVE DNDI

Heather Stone

Public Health Analyst
FDA

Durhane Wong-Rieger

President and Chief Executive Officer
CANADIAN ORGANIZATION FOR RARE DISORDERS

Jean-Antoine Zinsou

Head of Global Public Affairs, New Vaccines
SANOFI PASTEUR